Hasara Garrison J. 4
4 · HedgePath Pharmaceuticals, Inc. · Filed Mar 15, 2018
Insider Transaction Report
Form 4
Hasara Garrison J.
CEO, Secretary & Treasurer
Transactions
- Award
Common Stock Option
2018-03-13+260,000→ 260,000 totalExercise: $0.27From: 2018-03-13Exp: 2028-03-13→ Common Stock (260,000 underlying)